Feras Alfraih

International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL

Farrukh T. Awan, Daniel Addison, Feras Alfraih et al. · Blood Advances · 2022 · 62 citations · Full text

High-resolution HLA allele and haplotype frequencies of the Saudi Arabian population based on 45,457 individuals and corresponding stem cell donor matching probabilities

Feras Alfraih, Moheeb Al‐Awwami, Mahmoud Aljurf et al. · Human Immunology · 2020 · 23 citations · Full text

Histocompatibility, Hla, Saudi Arabia +23

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

Riad El Fakih, Alfadil Haroon, Feras Alfraih et al. · Bone Marrow Transplantation · 2021 · 21 citations · Full text

Clinical Course, Regional Report, Transplantation +11

Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community

Ameera Gaafar, Atia Sheereen, Fahad Almohareb et al. · Bone Marrow Transplantation · 2018 · 16 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +13

Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP)

Nora Alkhudair, Majed Alshamrani, Hadeel Samarkandi et al. · Saudi Pharmaceutical Journal · 2020 · 16 citations · Full text